Pharmaceutical News

RSS

Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system

Hologic, Inc. today announced completion of an agreement between its Cynosure division and Porter Instrument, a business unit of Parker Hannifin Corporation, for distribution rights in the United States and Canada to Porter Instrument’s nitrous oxide and oxygen system, Nitronox.

From Hologic, Inc. 17 Aug 2018

Statins may improve conditions of people with rare lung disease

In the first study of its kind, researchers have found that cholesterol-lowering statins may improve the conditions of people with a rare lung disease called autoimmune pulmonary alveolar proteinosis. The research also suggested that two new tests could help diagnose the condition.

17 Aug 2018

AGA urges policymakers and stakeholders to improve affordability of drugs

Increasing out-of-pocket expenses can limit access for patients, putting them at risk. Improving affordability requires a multi-faceted approach from across the health care system, including health insurers, drug and biologic manufacturers, and pharmacy benefit managers.

17 Aug 2018

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration approved KALYDECO® (ivacaftor) to include use in children with cystic fibrosis ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.

16 Aug 2018

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).

16 Aug 2018

Two thyroid medications recalled by FDA

The United States Food and Drug Administration (FDA) have announced the recall of two thyroid medications due to issues with their ingredients.

16 Aug 2018

New polyclonal immunotherapy successfully neutralizes Ebola virus

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.

15 Aug 2018

Powerful psychedelic compound can model near-death experiences in the brain

A powerful psychedelic compound found in ayahuasca can model near-death experiences in the brain, a study has found.

15 Aug 2018

Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines

A Johns Hopkins expert panel of health care providers and patients have announced what is, to their knowledge, the nation's first set of operation-specific opioid prescribing guidelines.

14 Aug 2018

New digital pharmacy aims to help people living with chronic care conditions

Thirty jobs are to be created through a new £1.5m ‘Tele-Pharmacy’opening in Liverpool, aimed at helping people living with chronic care conditions to manage their medicinal needs through the UK’s only artificial intelligent mobile app ‘Now Patient’.

From Infohealth Ltd 14 Aug 2018

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease in individuals who do not have asthma.

14 Aug 2018

Using peripheral nerve blocks to treat facial pain may produce long-term pain relief

A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia may produce long-term pain relief.

14 Aug 2018

New strategy accelerates, automates process of prototype molecule optimization

The search for new medicinal molecules with predetermined properties is a rather complex, expensive and time-consuming process, especially in oncology.

14 Aug 2018

Researchers develop new way of testing bacterial resistance to antibiotics

A new method to analyze a commonly understood route for antibiotic resistance could lead to earlier detection of antibiotic resistant bacteria.

14 Aug 2018

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.

14 Aug 2018

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.

14 Aug 2018

Long-term cannabinoid exposure impairs memory, study shows

A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.

13 Aug 2018

Study: Patients taking OTC drugs, dietary supplements not aware of effects on lab test results

Over-the-counter drugs and dietary supplements are widely used and popular, with US households spending an average of almost USD 350 annually on OTC products. In 2006 an average of EUR 67.50 was spent per person on OTC products in Germany.

13 Aug 2018

Study may help increase effectiveness of antibiotics against drug-resistant bacteria

Bacteria - especially Gram-negative strains - are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed.

13 Aug 2018

Pharmaceutical News

Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system

Statins may improve conditions of people with rare lung disease

AGA urges policymakers and stakeholders to improve affordability of drugs

FDA grants approval for first generic version of epinephrine auto-injector

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

Two thyroid medications recalled by FDA

New polyclonal immunotherapy successfully neutralizes Ebola virus

Powerful psychedelic compound can model near-death experiences in the brain

Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines

New digital pharmacy aims to help people living with chronic care conditions

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

Using peripheral nerve blocks to treat facial pain may produce long-term pain relief

New strategy accelerates, automates process of prototype molecule optimization

Researchers develop new way of testing bacterial resistance to antibiotics

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

Long-term cannabinoid exposure impairs memory, study shows

Study: Patients taking OTC drugs, dietary supplements not aware of effects on lab test results

Study may help increase effectiveness of antibiotics against drug-resistant bacteria

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Latest News